Aprea Therapeutics, Inc. (APRE) Reports Q2 Loss, Tops Revenue Estimates

Aprea Therapeutics, Inc. (APRE) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of$ 0.64. This compares to loss of $0.87 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 9.38%. A quarter ago, it was expected that this company would post a loss of$ 0.78 per share when it actually produced a loss of $0.67, delivering a surprise of 14.10%. Over the last four quarters, the company ha ...